Can you articulate a defensible, fundable strategy — and prove it?
Q1. How clearly defined is your company's strategic positioning — including target customer segment, differentiated value proposition, and primary revenue model?
Q2. How validated is your primary revenue model in terms of pricing, willingness to pay, and contract repeatability?
Q3. How well-defined and defensible is your competitive moat — whether IP, regulatory clearances, clinical data, or switching costs?
Q4. How credible and granular is your TAM/SAM/SOM analysis — and is it built bottom-up from real market intelligence?
Q5. How embedded is strategic planning into your operating rhythm — beyond the annual budgeting exercise?